Ledger.Open graph →
SEC Form D · filed November 14, 2023

HEMOSHEAR THERAPEUTICS, INC

Offering
$8.0M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHARLOTTESVILLE, VA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

H. T. Watkins Iii · Charlottesville, VADirectorJohn M. Tilton · Charlottesville, VADirectorKathleen M. Metters · Charlottesville, VADirectorBrian A. Johns · Charlottesville, VAExecDavid L. Friedman · Charlottesville, VADirectorAric R. Holsinger · Charlottesville, VAExecRobert J. Gould · Charlottesville, VADirectorAnn-Marie P. Campbell · ATLANTA, GAExecMatthew A. Carey · ATLANTA, GADirectorHector A. Padilla · ATLANTA, GADirectorJ. F. Brown · ATLANTA, GAExecJeffrey W. Boyd · ATLANTA, GADirectorJohn A. Deaton · ATLANTA, GADirectorTeresa W. Roseborough · ATLANTA, GADirectorMichael A. Innes · Charlottesville, VAExecPatrick A. Horn · Charlottesville, VAExecJohn L. Brooks Iii · Charlottesville, VADirectorBrian M. Warmhoff · Charlottesville, VAExec · DirectorAlan Kelly · Camana Bay, Grand Cayman, Cayman IslandsDirectorKevin A. Phillip · Camana Bay, Grand Cayman, Cayman IslandsDirectoriCapital HF GP, LLC · New York, NYDirectorEdgar T. Breeden Jr · Durham, NCExecFuze Fund, LLC · Durham, NCDirectorEdward Nalbandian · Whippany, NJDirectorSteven Temares · Whippany, NJExecMichael A. Innes · Charlottesville, VAExecPatrick A. Horn · Charlottesville, VAExecJohn L. Brooks Iii · Charlottesville, VADirectorBrian M. Warmhoff · Charlottesville, VAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗